Literature DB >> 23727544

Bupropion induced changes in exploratory and anxiety-like behaviour in NMRI male mice depends on the age.

M Carmen Carrasco1, Jose Vidal, Rosa Redolat.   

Abstract

The aim of this study was to assess the effects of the antidepressant bupropion on anxiety and novelty-seeking in adolescent mice of different ages and adults. Behavioural differences between early adolescent, late adolescent and adult NMRI mice were measured both in the elevated plus-maze and the hole-board tasks following acute administration of bupropion (5, 10, 15, 20mg/kg) or saline. In the plus maze test, early and late adolescent mice treated with bupropion (10, 15mg/kg, respectively) had lower percentages of entries in the open-arms compared to their vehicle controls. Adult mice treated with bupropion did not differ from their vehicle controls. These results suggest that the effect of this drug on anxiety-like behaviour in mice depends on the age, showing adolescents an anxiogenic-like profile. In the hole-board, adolescents showed more elevated levels of novelty-seeking than adults, exhibiting shorter latency to the first head-dip (HD) and a higher number of HD's. Bupropion increases the latency to the first HD and decreases the number of HD's in all age-groups, indicating a decline in exploratory tendency. Findings reveal that the age can modulate the behaviour displayed by mice in both animal models, and that adolescents are more sensitive to bupropion's anxiogenic effects.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescence; Anxiety; Bupropion; Elevated plus-maze; Hole-board; Novelty-seeking

Mesh:

Substances:

Year:  2013        PMID: 23727544     DOI: 10.1016/j.beproc.2013.05.002

Source DB:  PubMed          Journal:  Behav Processes        ISSN: 0376-6357            Impact factor:   1.777


  1 in total

1.  PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects.

Authors:  Ashenafi Mebratu Zewde; Frances Yu; Sunil Nayak; Christopher Tallarida; Allen B Reitz; Lynn G Kirby; Scott M Rawls
Journal:  J Neurosci Methods       Date:  2017-10-16       Impact factor: 2.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.